Proliferative index obtained by DNA image cytometry: Does it add prognostic information in Auer IV breast cancer?

Analytical and Quantitative Cytology and Histology

Volumn 20, Issue 2, 1998, Pages 144-152

  Baldetorp, Bo ^a,b   Fernö, Mårten ^a,b   Bendahl, Pär Ola ^a,b   Fallenius, Ghita ^a,b   Idvall, Ingrid ^a   Åkerman, Måns ^a   Killander, Dick ^a,b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

Breast neoplasms; DNA; Image cytometry; Prognosis

Indexed keywords

ARTICLE; BREAST CANCER; CANCER STAGING; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL PROLIFERATION; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MITOSIS INDEX; PRIORITY JOURNAL; PROGNOSIS;

BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; DNA, NEOPLASM; FEMALE; G2 PHASE; HUMANS; IMAGE CYTOMETRY; MITOSIS; PROGNOSIS; S PHASE; SURVIVORS;

EID: 0031943357     PISSN: 08846812     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (43)

1. Albe X, Vassilakos P, Helfer-Guarnori K, Givel J-C, de Quay N, Saurdet L, Eliason JF, Odartchenko N: Independent prognostic value of ploidy in colorectal cancer: A prospective study using image cytometry. Cancer 1990;66:1168-1175
2. Altman DG, Lausen B, Sauerbrei W, Schumacher M: Dangers of using "optimal" cutpoints in the evaluation of prognostic factors. J Natl Cancer Inst 1993;86:829-835
3. Atkin NB: Modal deoxyribonucleic acid value and survival in carcinoma of the breast. Br Med J 1972;1:271-272
4. Aubele M, Auer G, Falkmer U, Voss A, Rodenacker K, Rutquist L-E, Höfler H: Improved prognostication in small (pT1) breast cancers by image cytometry. Breast Cancer Res Treat 1995;36:83-91
5. Auer GU, Caspersson TO, Wallgren AS: DNA content and survival in mammary carcinoma. Analyt Quant Cytol 1980; 2:161-165
6. Auer G, Zetterberg A: The prognostic significance of nuclear DNA content in malignant tumors of breast, prostate and cartilage. In Advances in Clinical Cytology. Edited by LG Koss, DV Coleman. Second volume. New York, Masson Publishing, 1984, pp 123-134
7. Bacus SS, Bacus JW, Slamon DJ, Press M: HER-2/Neu oncogene expression and DNA ploidy analysis in breast cancer. Arch Pathol Lab Med 1990;114:164-169
8. Baisch H, Göhde W, Linden WA: Analysis of PCP-data to determine the fraction of cells in the various phases of cell cycle. Radiat Environ Biophys 1975;12:31-39
9. Baldetorp B, Dahlberg M, Holst U, Lindgren G: Statistical evaluation of cell kinetic data from DNA flow cytometry (FCM) by the EM algorithm. Cytometry 1989;10:695-705
10. Baldetorp B, Fernö M, Fallenius A, Fallenius-Vecchi G, Idvall I, Olsson H, Sigurdsson H, Åkerman M, Killander D: Image cytometric DNA analysis in human breast cancer analysis may add prognostic information in diploid cases with low S-phase fraction by flow cytometry. Cytometry 1992;13: 577-585
11. Böcking A, Adler C-P, Common HH, Hilgarth M, Granzen B, Auffermann W: Algorithm for DNA-cytophotometric diagnosis and grading of malignancy. Analyt Quant Cytol 1984; 6:1-8
12. Böcking A, Chatelain R, Biesterfeld S, Noll E, Biesterfeld D, Wohltmann D, Goecke C: DNA grading of malignancy in breast cancer: Prognostic validity, reproducibility and comparison with other classifications. Analyt Quant Cytol Histol 1989;11:73-80
13. Böhm N, Sandritter W: DNA in human tumors: A cytophotometric study. Curr Top Pathol 1975;60:151-219
14. Camplejohn RS, Ash CM, Gillett CE, Raikundalia B, Barnes DM, Gregory WM, Richards MA, Millis RR: The prognostic significance of DNA flow cytometry in breast cancer: Results from 881 patients treated in a single centre. Br J Cancer 1995; 71:140-145
15. Clark GM, Dressler LG, Owens MA, Pounds G, Oldaker T, McGuire WL: Prediction of relapse or survival in patients with node-negative breast cancer by DNA flow cytometry. N Engl J Med 1989;320:627-633
16. Clark GM, Mathieu M-C, Owens MA, Dressler LG, Eudey L, Tormey DC, Osborne CK, Gilchrist KW, Mansour EG, Abeloff MD, McGuire WL: Prognostic significance of S-phase fraction in good-risk, node-negative breast cancer patients. J Clin Oncol 1992;10:428-432
17. Claud RD III, Weinstein RS, Howeedy A, Straus AK, Coon JS: Comparison of image analysis of imprints with flow cytometry for DNA analysis of solid rumors. Mod Pathol 1989; 2:463-467
18. Cornelisse CJ, Van de Velde CJH, Caspers RJC, Moolenaar AJ, Hermans J: DNA ploidy and survival in breast cancer patients. Cytometry 1987;8:225-234
19. Decosse JJ, Aiello N: Feulgen hydrolysis: Effect of acid and temperature. J Histochem Cytochem 1966;14:601-604
20. Dressler LG, Eudey L, Gray R, Tormey DC, McGuire WL, Gilchrist KW, Clark GM, Osborne CK, Mansour EG, Abeloff MD, et al: Prognostic potential of DNA flow cytometry measurements in node-negative breast cancer patients: Preliminary analysis of an intergroup study (INT 0076). J Natl Cancer Inst Monogr 1992;11:167-172
21. Elsheikh TM, Silverman JF, McCool JW, Riley RS: Comparative DNA analysis of solid tumors by flow cytometric and image analyses of touch imprints and flow cell suspensions. Am J Clin Pathol 1992;98:296-304
22. Falkmer UG: Methodological aspects on DNA cytometry: Image and flow cytometry on malignant tumours of the breast, the endometrium, the brain, and the salivary glands. Doctoral thesis, T-Tryck, Stockholm University, Stockholm, 1989
23. Fallenius AG, Auer GU, Carstensen JM: Prognostic significance of DNA measurements in 409 consecutive breast cancer patients. Cancer 1988;62:331-341
24. Fernö M, Baldetorp B, Borg Å, Olsson H, Sigurdsson H, Killander D: Flow cytometric DNA index and S-phase fraction in breast cancer in relation to other prognostic variables and to clinical outcome. Acta Oncol 1992;31:157-165
25. Gaub J, Auer G, Zetterberg A: Quantitative cytochemical aspects of a combined Feulgen-naphtol yellow S staining procedure for the simultaneous determination of nuclear and cytoplasmic proteins and DNA in mammalian cells. Exp Cell Res 1975;92:323-332
26. Hatschek T, Gröntoft O, Fagerberg G, Stal O, Sullivan S, Carstensen J, Nordenskjöld B: Cytometric and histopathologic features of tumors detected in a randomized mammography screening program: Correlation and relative prognostic influence. Breast Cancer Res Treat 1990;15: 149-160
27. Hedley DW, Rugg CA, Gelber RD: Association of DNA index and S-phase fraction with prognosis of node positive early breast cancer. Cancer Res 1987;47:4729-4735
28. Hiddemann W, Schumann J, Andreeff M, Barlogie B, Herman CJ, Leif RC, Mayall BH, Murphy RF, Sandberg AA: Convention on nomenclature for DNA cytometry. Cytometry 1984;5:445-446
29. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Koivula T: Tumour DNA ploidy as an independent prognostic factor in breast cancer. Br J Cancer 1987;56:637-642
30. Kallioniemi OP, Blanco G, Alavaikko M, Hietanen T, Mattila J, Lauslahti K, Lehtinen M, Koivula T: Improving the prognostic value of DNA flow cytometry in breast cancer by combining DNA index and S-phase fraction: A proposed classification of DNA histograms in breast cancer. Cancer 1988; 62:2183-2190
31. Klintenberg C, Wallgren A, Bjelkenkrantz K, Carstenssen J, Humla S, Nordenskjöld B, Skoog L: DNA distribution, cytosol estrogen receptors and axillary nodes as prognostic predictors in breast carcinoma. Acta Radiol Oncol 1985;24: 253-258
32. Montironi R, Diamanti L, Santinelli A, Scarpelli M: Computer-aided S-phase fraction determination in DNA static cytometry in breast cancer: A preliminary methodologic study on cytologic material. Analyt Quant Cytol Histol 1992;14: 379-385
33. Norgren A, Borg Å, Fernö M, Johansson U, Lindahl B, Tsiobanelis K: Improved method of assay of estradiol and progesterone receptors with special reference to breast cancer. Anticancer Res 1982;2:315-320
34. Opfermann M, Brugal G, Vassilakos P: Cytometry of breast carcinoma: Significance of ploidy balance and proliferation index. Cytometry 1987;8:217-224
35. O'Reilly SM, Camplejohn RS, Barnes DM: DNA index, S-phase fraction, histological grade and prognosis in breast cancer. Br J Cancer 1990;61:671-674
36. Ploem JS, van Driel-Kulker AMJ, Ploem-Zaaijer JJ: Automated cell analysis for DNA studies of large cell populations using the Leytas image cytometry system. Pathol Res Pract 1989;185:671-675
37. Schoenfeld D: Chi-squared goodness-of-fit test for the proportional hazards regression model. Biometrika 1980;67: 145-153
38. Seigneurin D, Louis J, Villoud M-C: The value of DNA image cytometry for the cytological diagnosis of well-differentiated breast carcinomas and benign lesions. Anal Cell Pathol 1994; 7:115-125
39. Sigurdsson H, Baldetorp B, Borg Å., Dalberg M, Fernö M, Killander D, Olsson H: Indicators of prognosis in node-negative breast cancer. N Engl J Med 1990;332:1045-1053
40. Stenkvist B, Strande G: Entropy as an algorithm for the statistical description of DNA cytometric data obtained by image analysis microscopy. Anal Cell Pathol 1990;2: 159-165
41. van der Linden JC, Lindeman J, Baak JP, Meijer CJ, Herman CJ: The multivariate prognostic index and nuclear DNA content are independent prognostic factors in primary breast cancer patients. Cytometry 1989;10:56-61
42. Wagner T, Adler A, Kubista E: S-phasen-fraktion und der anteil an zellen mit hohem DNA-gehalt als prognostische Faktoren des Lymphknoten-negativen Mammarkarzinoms. Wien Klin Wochenschr 1993;105:712-714
43. Witzig TE, Ingle JN, Cha SS, Schaid DJ, Tabery RL, Wold LE, Grant C, Gonchoroff NJ, Katzmann JA: DNA ploidy and the percentage of cells in S-phase as prognostic factors for women with lymph node negative breast cancer. Cancer 1994;74:1752-1761